tiprankstipranks
Advertisement
Advertisement

HK:6185 Stock Latest News

CanSino Biologics Q1 2026 Revenue Rises but Loss Widens
Company AnnouncementsCanSino Biologics Q1 2026 Revenue Rises but Loss Widens
8d ago
CanSino Biologics Tightens Governance With Proposed Articles and Board Rule Changes
PremiumCompany Announcements
CanSino Biologics Tightens Governance With Proposed Articles and Board Rule Changes
8d ago
CanSino Biologics Sets April 28 Board Meeting to Approve Q1 2026 Results
PremiumCompany Announcements
CanSino Biologics Sets April 28 Board Meeting to Approve Q1 2026 Results
20d ago
CanSino Wins China Approval for First DTcP Components Infant Vaccine
PremiumCompany Announcements
CanSino Wins China Approval for First DTcP Components Infant Vaccine
23d ago
CanSino Biologics Publishes Audited 2025 Annual Results and Readies Full Report
PremiumCompany Announcements
CanSino Biologics Publishes Audited 2025 Annual Results and Readies Full Report
1M ago
CanSino Biologics Sets March 30 Board Meeting to Approve 2025 Results
PremiumCompany AnnouncementsCanSino Biologics Sets March 30 Board Meeting to Approve 2025 Results
2M ago
CanSino Biologics Wins PIC/S GMP Nod for Key Conjugate Vaccines
Premium
Company Announcements
CanSino Biologics Wins PIC/S GMP Nod for Key Conjugate Vaccines
2M ago
CanSino Biologics Swings to Preliminary 2025 Profit on Higher Revenue
Premium
Company Announcements
CanSino Biologics Swings to Preliminary 2025 Profit on Higher Revenue
2M ago
CanSino Wins China Nod to Extend Use of Menhycia Pediatric Vaccine
PremiumCompany Announcements
CanSino Wins China Nod to Extend Use of Menhycia Pediatric Vaccine
2M ago
CanSino Biologics Forecasts 2025 Revenue Growth and Return to Profit
PremiumCompany Announcements
CanSino Biologics Forecasts 2025 Revenue Growth and Return to Profit
3M ago
CanSino Wins China Trial Nod for First-in-Class 24-Valent Pneumococcal Vaccine
PremiumCompany Announcements
CanSino Wins China Trial Nod for First-in-Class 24-Valent Pneumococcal Vaccine
4M ago
CanSino Biologics Starts Phase I Trial of New Pediatric Combined Vaccine
PremiumCompany Announcements
CanSino Biologics Starts Phase I Trial of New Pediatric Combined Vaccine
5M ago
CanSino Biologics Implements Governance Changes Post-EGM
PremiumCompany AnnouncementsCanSino Biologics Implements Governance Changes Post-EGM
5M ago
CanSino Biologics Launches Phase I Trial for Inhaled TB Booster in Indonesia
Premium
Company Announcements
CanSino Biologics Launches Phase I Trial for Inhaled TB Booster in Indonesia
6M ago
CanSino Biologics to Revamp Governance and Appoint New Directors at 2025 EGM
Premium
Company Announcements
CanSino Biologics to Revamp Governance and Appoint New Directors at 2025 EGM
6M ago
CanSino Biologics to Offset Losses with Reserves
PremiumCompany Announcements
CanSino Biologics to Offset Losses with Reserves
6M ago
CanSino Biologics Enhances Governance with New Committee
PremiumCompany Announcements
CanSino Biologics Enhances Governance with New Committee
6M ago
CanSino Biologics Proposes Governance Restructuring
PremiumCompany Announcements
CanSino Biologics Proposes Governance Restructuring
6M ago
CanSino Biologics Strengthens Governance with New Audit Committee
PremiumCompany Announcements
CanSino Biologics Strengthens Governance with New Audit Committee
6M ago
CanSino Biologics Inc. Enhances Governance with New Nomination Committee
PremiumCompany AnnouncementsCanSino Biologics Inc. Enhances Governance with New Nomination Committee
6M ago
CanSino Biologics Reports Strong Q3 Financial Performance
Premium
Company Announcements
CanSino Biologics Reports Strong Q3 Financial Performance
6M ago
CanSino Biologics Approves H Share Option Scheme at 2025 EGM
Premium
Company Announcements
CanSino Biologics Approves H Share Option Scheme at 2025 EGM
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >